For a drug protected across Germany, France, Italy, Spain, the Netherlands, and Switzerland, the combined annual European annuity payments for a single patent can reach EUR 15,000 to EUR 25,000 in mid-life, rising further in later years
The following is not intended to be medical or treatment advice
Medicare Utilization of GLP-1s Rises with Broader Indications Beyond Obesity Since Medicare does not cover anti obesity drugs when prescribed solely for weight management, utilization of weight loss indicated GLP-1s historically lagged behind their use in commercial markets
PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat pricing, making the transition cost-transparent
Lo recomiendo
Wegovy is also FDA-approved to reduce the risk of cardiovascular events in adults with established cardiovascular disease and either overweight or obesity